Because the enzymes COMT and CYP1A1 are closely related and work in metabolic sequence in the metabolism of estrogens, it is important to examine if the functional polymorphisms of these enzymes in association change the risk to develop cervical cancer in the carriers. The gene discussed is CYP1A1; the disease is cervical carcinoma.